Search
for
Sort by
Research 151–180 of 1000+
- Trichodynia: a review of the literature
- Atlas of Geriatric Dermatology
- The Itchy Scalp
- Therapies
- Letters to the Editor
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- A case report of Graham-Little–Piccardi–Lassueur syndrome
- Intense Pulsed Light: From the Past to the Future
- Chilblains in Turkey: a case-control study
- An overview of the role of carboxytherapy in dermatology
- Folliculotropic CD8+ mycosis fungoides associated with diffuse mucosal involvement
- [Translated article] Sensitive Scalp: Diagnosis and Practical Management
- Recurrent pruritic polymorphic lesions associated with weight loss
- Atypical Presentation of Systemic Lupus Erythematous with Vasculitic Polyneuropathy
- Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90
- Skin manifestations associated with systemic diseases – Part I
- Trace element zinc and skin disorders
- Comparative Efficacy Study Combination of Oral Methotrexate and Prednisolone versus Oral Methotrexate in Patients with Lichen Planopilaris
- A randomized comparative study between intralesional vitamin D3 and intralesional triamcinolone acetonide in the treatment of alopecia areata
- Low‐Dose Oral Minoxidil in Lichen Planopilaris: Efficacy and Safety
- A Series of Clinical Cases of Psychocutaneous Disorders in a Dermatology Unit in Albania
- An ancestral recipe of “Champigny Saumure” to be used tepid by topical way could be useful to combat Patton-Lynch’s Erosive pustular dermatosis of the scalp
- Hair Disorders in Autoimmune Diseases
- 1,314
- The use of NDYAG laser combined with pulsed light in the treatment of rosacea
- The Wonder Tool Platelet Rich Plasma in Cosmetic Dermatology, Trichology and Hair Transplant
- Nanoparticle-Based Targeting of Vaccine Compounds to Skin Antigen-Presenting Cells By Hair Follicles and their Transport in Mice
- Topical absorption and systemic toxicity
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program